BioEnergy International Acquires Assets of OmniGene Bioproducts

Luke Timmerman7/21/08

BioEnergy International, a privately-held developer of biofuels and renewable biochemicals based in Quincy, MA, said it has acquired certain assets from Cambridge, MA-based OmniGene Bioproducts. The acquisition gives BioEnergy skilled employees in molecular biology, cell biology and fermentation technology, the company said. Financial terms of the agreement weren’t disclosed.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.